Chemical approaches for the enhancement of porphyrin skeleton-based photodynamic therapy

References

• Wong MCS, Lao XQ, Ho KF, et al. Incidence and mortality of lung cancer: global trends and association with socioeconomic status. Sci Rep 2017;7:14300.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020;70:7–30.
   PubMed Web of Science ®Google Scholar
• Yano S, Hirohara S, Obata M, et al. Current states and future views in photodynamic therapy. J Photochem Photobiol C 2011;12:46–67.
   Google Scholar
• Dougherty TJ, Kaufman JE, Goldfarb A, et al. Photoradiation therapy for the treatment of malignant tumors. Cancer Res 1978;38:2628–35.
   PubMed Web of Science ®Google Scholar
• Habermeyer B, Guilard R. Some activities of PorphyChem illustrated by the applications of porphyrinoids in PDT, PIT and PDI. Photochem Photobiol Sci 2018;17:1675–90.
   PubMed Web of Science ®Google Scholar
• Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer 2003;3:380–7.
   PubMed Web of Science ®Google Scholar
• Li X, Lee S, Yoon J. Supramolecular photosensitizers rejuvenate photodynamic therapy. Chem Soc Rev 2018;47:1174–88.
   PubMed Web of Science ®Google Scholar
• Levy J, Photofrin-PDT from bench to bedside: some lessons learned. In: Pandey RK, Dougherty TJ, Kessel D, eds. Handbook of photodynamic therapy: updates on recent applications of porphyrin-based compounds. Singapore: World Scientific Publishing; 2016.
   Google Scholar
• Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin 2011;61:250–81.
   PubMed Web of Science ®Google Scholar
• Gomes A, Neves M, Cavaleiro J. Cancer, photodynamic therapy and porphyrin-type derivatives. An Acad Bras Cienc 2018;90:993–1026.
   PubMed Web of Science ®Google Scholar
• Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. Photodiagn Photodyn Ther 2004;1:279–93.
   PubMed Web of Science ®Google Scholar
• Ethirajan M, Chen Y, Joshi P, Pandey RK. The role of porphyrin chemistry in tumor imaging and photodynamic therapy. Chem Soc Rev 2011;40:340–62.
   PubMed Web of Science ®Google Scholar
• Martinez D, Mroz P, Thunshelle C, Hamblin MR. Design features for optimization of tetrapyrrole macrocycles as antimicrobial and anticancer photosensitizers. Chem Biol Drug Des 2017;89:192–206.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Tian XD, Ai HW. Molecular tools to generate reactive oxygen species in biological systems. Bioconjugate Chem 2019;30:1297–303.
   PubMed Web of Science ®Google Scholar
• Liu C, Dobhal MP, Ethirajan M, et al. Highly selective synthesis of the ring-B reduced chlorins by ferric chloride-mediated oxidation of bacteriochlorins: effects of the fused imide vs isocyclic ring on photophysical and electrochemical properties. J Am Chem Soc 2008;130:14311–23.
   PubMed Web of Science ®Google Scholar
• Feng X, Shi Y, Xie L, et al. Synthesis, characterization, and biological evaluation of a porphyrin-based photosensitizer and its isomer for effective photodynamic therapy against breast cancer. J Med Chem 2018;61:7189–720.
   PubMed Web of Science ®Google Scholar
• Zhu S, Yao S, Wu F, et al. Platinated porphyrin as a new organelle and nucleus dual-targeted photosensitizer for photodynamic therapy. Org Biomol Chem 2017;15:5764–71.
   PubMed Web of Science ®Google Scholar
• Stacey OJ, Pope SJA. New avenues in the design and potential application of metal complexes for photodynamic therapy. RSC Adv 2013;3:25550–64.
   Web of Science ®Google Scholar
• Zhang J, Jiang CS, Longo JPF, et al. An updated overview on the development of new photosensitizers for anticancer photodynamic therapy. Acta Pharm Sin B 2018;8:137–46.
   PubMed Web of Science ®Google Scholar
• Bůžek D, Zelenka J, Ulbrich P, et al. Nanoscaled porphyrinic metal–organic frameworks: photosensitizer delivery systems for photodynamic therapy. J Mater Chem B 2017;5:1815–21.
   PubMed Web of Science ®Google Scholar
• Hynek J, Ondrušová S, Bůžek D, et al. Postsynthetic modification of a zirconium metal-organic framework at the inorganic secondary building unit with diphenylphosphinic acid for increased photosensitizing properties and stability. Chem Commun 2017;53:8557–60.
   PubMed Web of Science ®Google Scholar
• Boni LD, Monteiro CJP, Mendonça CR, et al. Influence of halogen atoms and protonation on the photophysical properties of sulfonated porphyrins. Chem Phys Lett 2015;633:146–51.
   Web of Science ®Google Scholar
• Kessel D, Thompson P, Saatio K, Nantwi KD. Tumor localization and photosensitization by sulfonated derivatives of tetraphenylporphine. Photochem Photobiol 1987;45:787–90.
   PubMed Web of Science ®Google Scholar
• Winkelman JW, Collins GH. Neurotoxicity of tetraphenylporphinesulfonate TPPS4 and its relation to photodynamic therapy. Photochem Photobiol 1987;46:801–7.
   PubMed Web of Science ®Google Scholar
• Thomas AP, Saneesh Babu PS, Ramakrishnan S, et al. meso-Tetrakis(p-sulfonatophenyl)N-confused porphyrin tetrasodium salt: a potential sensitizer for photodynamic therapy. J Med Chem 2012;55:5110–20.
   PubMed Web of Science ®Google Scholar
• Hynek J, Koncosova M, Zelenka J, et al. Phosphinatophenylporphyrins tailored for high photodynamic efficacy. Org Biomol Chem 2018;16:7274–81.
   PubMed Web of Science ®Google Scholar
• You Y, Gibson SL, Hilf R, et al. Water soluble, core-modified porphyrins. 3. Synthesis, photophysical properties, and in vitro studies of photosensitization, uptake, and localization with carboxylic acid-substituted derivatives. J Med Chem 2003;46:3734–47.
   PubMed Web of Science ®Google Scholar
• Stilts CE, Nelen MI, Hilmey DG, et al. Water-soluble, core-modified porphyrins as novel, longer-wavelength-absorbing sensitizers for photodynamic therapy. J Med Chem 2000;43:2403–10.
   PubMed Web of Science ®Google Scholar
• Wilkinson F, Helman WP, Ross AB. Quantum yields for the photosensitized formation of the lowest electronically excited singlet state of molecular oxygen in solution. J Phys Chem Ref Data 1993;22:113–262.
   Web of Science ®Google Scholar
• Hilmey DG, Abe M, Nelen M, et al. Water-soluble, core-modified porphyrins as novel, longer-wavelength-absorbing sensitizers for photodynamic therapy. II. Effects of core heteroatoms and meso-substituents on biological activity. J Med Chem 2002;45:449–61.
   PubMed Web of Science ®Google Scholar
• McMillin DR, Shelton AH, Bejune SA, et al. Understanding binding interactions of cationic porphyrins with B-form DNA. Coord Chem Rev 2005;249:1451–9.
   Web of Science ®Google Scholar
• Slomp AM, Barreira SMW, Carrenho LZB, et al. Photodynamic effect of meso-(aryl)porphyrins and meso-(1-methyl-4-pyridinium)porphyrins on HaCaT keratinocytes. Bioorg Med Chem Lett 2017;27:156–61.
   PubMed Web of Science ®Google Scholar
• Jensen TJ, Vicente MGH, Luguya R, et al. Effect of overall charge and charge distribution on cellular uptake, distribution and phototoxicity of cationic porphyrins in HEp2 cells. J Photochem Photobiol B 2010;100:100–11.
   PubMed Web of Science ®Google Scholar
• Kumar D, Shekar KPC, Mishra B, et al. Cationic porphyrin-quinoxaline conjugate as a photochemically triggered novel cytotoxic agent. Bioorg Med Chem Lett 2013;23:3221–4.
   PubMed Web of Science ®Google Scholar
• Jelovica M, Grbcic P, Muskovic M, et al. In vitro photodynamic activity of N-methylated and N-oxidised tripyridyl porphyrins with long alkyl chains and their inhibitory activity in sphingolipid metabolism. ChemMedChem 2018;13:360–72.
   PubMed Web of Science ®Google Scholar
• Harris PA, Cheung M, Hunter IIR, et al. Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitors. J Med Chem 2005;48:1610–9.
   PubMed Web of Science ®Google Scholar
• Zheng YM, Wang K, Li T, et al. Synthesis, singlet oxygen photogeneration and DNA photocleavage of porphyrins with nitrogen heterocycle tails. Molecules 2011;16:3488–98.
   PubMed Web of Science ®Google Scholar
• Sari MA, Battioni JP, Dupre D, et al. Interaction of cationic porphyrins with DNA: importance of the number and position of the charges and minimum structural requirements for intercalation. Biochemistry 1990;29:4205–15.
   PubMed Web of Science ®Google Scholar
• Dutikova YV, Borisova OF, Shchyolkina AK, et al. 5,10,15,20-Tetra-(N-methyl-3-pyridyl)porphyrin destabilizes the antiparallel telomeric quadruplex d(TTAGGG)4. Mol Biol 2010;44:823–31.
   Web of Science ®Google Scholar
• Antoni PM, Naik A, Albert I, et al. (Metallo)porphyrins as potent phototoxic anti-cancer agents after irradiation with red light. Chem Eur J 2015;21:1179–83.
   PubMed Web of Science ®Google Scholar
• Yoho J, Wogensthal K, Bennett TL, et al. Water-soluble zinc porphyrin capable of light-induced photocleavage of DNA: cell localization studies in Drosophila melanogaster and light activated treatment of lung cancer cells. Eur J Inorg Chem 2017;2017:153–9.
   Google Scholar
• Rice KP, Penketh PG, Shyam K, Sartorelli AC. Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine™ and BCNU. Biochem Pharmacol 2005;69:1463–72.
   PubMed Web of Science ®Google Scholar
• Elms J, Beckett PN, Griffin P, Curran AD. Mechanisms of isocyanate sensitisation. An in vitro approach. Toxicol in Vitro 2001;15:631–4.
   PubMed Web of Science ®Google Scholar
• Silva P, Fonseca SM, Arranja CT, et al. A new nonconjugated naphthalene derivative of meso-tetra-(3-hydroxy)-phenyl-porphyrin as a potential sensitizer for photodynamic therapy. Photochem Photobiol 2010;86:1147–53.
   PubMed Web of Science ®Google Scholar
• William B, Reinhold T. Silicon chemistry as a novel source of chemical diversity in drug design. Curr Opin Drug Discov Devel 2003;6:526–43.
   PubMedGoogle Scholar
• Jiang XJ, Lo PC, Yeung SL, et al. A pH-responsive fluorescence probe and photosensitiser based on a tetraamino silicon (IV) phthalocyanine. ChemCommun 2010;46:3188–90.
   PubMed Web of Science ®Google Scholar
• Horiuchi H, Hosaka M, Mashio H, et al. Silylation improves the photodynamic activity of tetraphenylporphyrin derivatives in vitro and in vivo. Chem Eur J 2014;20:6054–60.
   PubMed Web of Science ®Google Scholar
• Morlière P, Momenteau M, Candide C, et al. Synthesis, cellular uptake of, and cell photo-sensitization by a porphyrin bearing a quinoline group. J Photochem Photobiol B 1990;5:49–67.
   PubMed Web of Science ®Google Scholar
• Costa LD, Silva JA, Fonseca SM, et al. Photophysical characterization and in vitro phototoxicity evaluation of 5,10,15,20-tetra(quinolin-2-yl)porphyrin as a potential sensitizer for photodynamic therapy. Molecules 2016;21:439.
   PubMed Web of Science ®Google Scholar
• Rangasamy S, Ju H, Um S, et al. Mitochondria and DNA targeting of 5,10,15,20-tetrakis(7-sulfonatobenzo[b]thiophene) porphyrin-induced photodynamic therapy via intrinsic and extrinsic apoptotic cell death. J Med Chem 2015;58:6864–74.
   PubMed Web of Science ®Google Scholar
• Frederiksen LJ, Sullivan R, Maxwell LR, et al. Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling. Clin Cancer Res 2007;13:2199–206.
   PubMed Web of Science ®Google Scholar
• Liu WK, Liu CZ, Gong CJ, et al. Porphyrins containing nitric oxide donors: synthesis and cancer cell-oriented NO release. Bioorg Med Chem Lett 2009;19:1647–9.
   PubMed Web of Science ®Google Scholar
• Li JW, Wu ZM, Magetic D, et al. Antitumor effects evaluation of a novel porphyrin derivative in photodynamic therapy. Tumour Biol 2015;36:9685–92.
   PubMedGoogle Scholar
• Stefano B, Enrico C, Stefania C, et al. Photodynamic effects of porphyrin and chlorin photosensitizers in human colon adenocarcinoma cells. Bioorg Med Chem 2004;12:4853–60.
   PubMed Web of Science ®Google Scholar
• Hudson R, Savoie H, Boyle RW. Lipophilic cationic porphyrins as photodynamic sensitisers – synthesis and structure-activity relationships. Photodiagn Photodyn Ther 2005;2:193–6.
   PubMed Web of Science ®Google Scholar
• Liao PY, Wang XR, Gao YH, et al. Synthesis, photophysical properties and biological evaluation of β-alkylaminoporphyrin for photodynamic therapy. Bioorg Med Chem 2016;24:6040–7.
   PubMed Web of Science ®Google Scholar
• Wang K, Poon CT, Choi CY, et al. Synthesis, circular dichroism, DNA cleavage and singlet oxygen photogeneration of 4-amidinophenyl porphyrins. J Porphyrins Phthalocyanines 2012;16:85–92.
   Web of Science ®Google Scholar
• Zhu S, Wu F, Wang K, et al. Photocytotoxicity, cellular uptake and subcellular localization of amidinophenylporphyrins as potential photodynamic therapeutic agents: An in vitro cell study. Bioorg Med Chem Lett 2015;25:4513–7.
   PubMed Web of Science ®Google Scholar
• Greenwald RB. PEG drugs: an overview. J Control Release 2001;74:159–71.
   PubMed Web of Science ®Google Scholar
• Sibrian-Vazquez M, Jensen TJ, Vicente M. Synthesis and cellular studies of PEG-functionalized meso-tetraphenylporphyrins. J Photochem Photobiol B 2007;86:9–21.
   PubMed Web of Science ®Google Scholar
• Králová J, Bříza T, Moserová I, et al. Glycol porphyrin derivatives as potent photodynamic inducers of apoptosis in tumor cells. J Med Chem 2008;51:5964–73.
   PubMed Web of Science ®Google Scholar
• Schneider R, Schmitt F, Frochot C, et al. Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy. Bioorg Med Chem 2005;13:2799–808.
   PubMed Web of Science ®Google Scholar
• Stallivieri A, Colombeau L, Jetpisbayeva G, et al. Folic acid conjugates with photosensitizers for cancer targeting in photodynamic therapy: synthesis and photophysical properties. Bioorg Med Chem 2017;25:1–10.
   PubMed Web of Science ®Google Scholar
• Lang K, Král VR, Kapusta P, et al. Photoinduced electron transfer within porphyrin–cyclodextrin conjugates. Tetrahedron Lett 2002;43:4919–22.
   Web of Science ®Google Scholar
• Vyas A, Saraf S, Saraf S. Cyclodextrin based novel drug delivery systems. J Incl Phenom Macrocycl Chem 2008;62:23–42.
   Web of Science ®Google Scholar
• Zhang J, Ma PX. Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective. Adv Drug Deliv Rev 2013;65:1215–33.
   PubMed Web of Science ®Google Scholar
• Carofiglio T, Fornasier R, Lucchini V, et al. Synthesis, characterization, and supramolecular properties of a hydrophilic porphyrin–beta-cyclodextrin conjugate. J Org Chem 2000;65:9013–21.
   PubMed Web of Science ®Google Scholar
• Kralova J, Synytsya A, Pouckova P, et al. Novel porphyrin conjugates with a potent photodynamic antitumor effect: differential efficacy of mono- and bis-β-cyclodextrin derivatives in vitro and in vivo. Photochem Photobiol 2006;82:432–8.
   PubMed Web of Science ®Google Scholar
• Thomas T, Thomas TJ. Polyamine metabolism and cancer. J Cell Mol Med 2003;7:113–26.
   PubMed Web of Science ®Google Scholar
• Sol V, Lamarche F, Enache M, et al. Polyamine conjugates of meso-tritolylporphyrin and protoporphyrin IX: potential agents for photodynamic therapy of cancers. Bioorg Med Chem 2006;14:1364–77.
   PubMed Web of Science ®Google Scholar
• Fidanzi-Dugas C, Liagre B, Chemin G, et al. Analysis of the in vitro and in vivo effects of photodynamic therapy on prostate cancer by using new photosensitizers, protoporphyrin IX-polyamine derivatives. Biochim Biophys Acta 2017;1861:1676–90.
   Web of Science ®Google Scholar
• Sarrazy V, Garcia G, Mbakidi JP, et al. Photodynamic effects of porphyrin–polyamine conjugates in human breast cancer and keratinocyte cell lines. J Photochem Photobiol B 2011;103:201–6.
   PubMed Web of Science ®Google Scholar
• Lupu M, Maillard P, Mispelter J, et al. A glycoporphyrin story: from chemistry to PDT treatment of cancer mouse models. Photochem Photobiol Sci 2018;17:1599–611.
   PubMed Web of Science ®Google Scholar
• Laville I, Figueiredo T, Loock B, et al. Synthesis, cellular internalization and photodynamic activity of glucoconjugated derivatives of tri and tetra(meta-hydroxyphenyl)chlorins. Bioorg Med Chem 2003;11:1643–52.
   PubMed Web of Science ®Google Scholar
• Desroches MC, Bautista-Sanchez A, Lamotte C, et al. Pharmacokinetics of a tri-glucoconjugated 5,10,15-(meta)-trihydroxyphenyl-20-phenyl porphyrin photosensitizer for PDT. A single dose study in the rat. J Photochem Photobiol B 2006;85:56–64.
   PubMed Web of Science ®Google Scholar
• Laville I, Pigaglio S, Blais JC, et al. Photodynamic efficiency of diethylene glycol-linked glycoconjugated porphyrins in human retinoblastoma cells. J Med Chem 2006;49:2558–67.
   PubMed Web of Science ®Google Scholar
• Maillard P, Loock B, Grierson DS, et al. In vitro phototoxicity of glycoconjugated porphyrins and chlorins in colorectal adenocarcinoma (HT29) and retinoblastoma (Y79) cell lines. Photodiagn Photodyn Ther 2007;4:261–8.
   PubMed Web of Science ®Google Scholar
• Ashry E, Awad LF, Atta AI. Synthesis and role of glycosylthio heterocycles in carbohydrate chemistry. Tetrahedron 2006;62:2943–98.
   Web of Science ®Google Scholar
• Sylvain I, Zerrouki R, Granet R, et al. Synthesis and biological evaluation of thioglycosylated porphyrins for an application in photodynamic therapy. Bioorg Med Chem 2002;10:57–69.
   PubMed Web of Science ®Google Scholar
• Kaldapa C, Blais JC, Carré V, et al. Synthesis of new glycosylated neutral and cationic porphyrins dimers. Tetrahedron Lett 2000;41:331–5.
   Web of Science ®Google Scholar
• Ahmed S, Davoust E, Savoie H, et al. Thioglycosylated cationic porphyrins – convenient synthesis and photodynamic activity in vitro. Tetrahedron Lett 2004;45:6045–7.
   Web of Science ®Google Scholar
• Stasio BD, Frochot C, Dumas D, et al. The 2-aminoglucosamide motif improves cellular uptake and photodynamic activity of tetraphenylporphyrin. Eur J Med Chem 2005;40:1111–22.
   PubMed Web of Science ®Google Scholar
• Ballut S, Makky A, Chauvin B, et al. Tumor targeting in photodynamic therapy. From glycoconjugated photosensitizers to glycodendrimeric one. Concept, design and properties. Org Biomol Chem 2012;10:4485–95.
   PubMed Web of Science ®Google Scholar
• Ballardini R, Colonna B, Gandolfi MT, et al. Porphyrin-containing glycodendrimers. Eur J Org Chem 2003;2003:288–94.
   Web of Science ®Google Scholar
• Ballut S, Makky A, Loock B, et al. New strategy for targeting of photosensitizers. Synthesis of glycodendrimeric phenylporphyrins, incorporation into a liposome membrane and interaction with a specific lectin. ChemCommun 2009;8:224–6.
   Google Scholar
• Griegel S, Rajewsky MF, Ciesiolka T, Gabius HJ. Endogenous sugar receptor (lectin) profiles of human retinoblastoma and retinoblast cell lines analyzed by cytological markers, affinity chromatography and neoglycoprotein-targeted photolysis. Anticancer Res 1989;9:723–30.
   PubMed Web of Science ®Google Scholar
• Wang ZJ, Chauvin B, Maillard P, et al. Glycodendrimeric phenylporphyrins as new candidates for retinoblastoma PDT: blood carriers and photodynamic activity in cells. J Photochem Photobiol B 2012;115:16–24.
   PubMed Web of Science ®Google Scholar
• Daghildjian K, Kasselouri A, N’Diaye M, et al. Mannose distribution in glycoconjugated tetraphenylporphyrins governs their uptake mechanism and phototoxicity. J Porphyrins Phthalocyanines 2019;23:175–84.
   Web of Science ®Google Scholar
• Lovejoy KS, Lippard SJ. Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting. Dalton Trans 2009;28:10651–9.
   Google Scholar
• Zhang Z, Yu HJ, Wu S, et al. Synthesis, characterization, and photodynamic therapy activity of 5,10,15,20-Tetrakis. (Carboxyl)Porphyrin. Bioorg Med Chem 2019;27:2598–608.
   PubMedGoogle Scholar
• Zhou X, Tse MK, Wan TS, et al. Synthesis of beta-mono-, tetra-, and octasubstituted sterically bulky porphyrins via Suzuki Cross Coupling. J Org Chem 1996;31:3590–3.
   Google Scholar
• Huang Q, Pan ZQ, Wang P, et al. Zinc(II) and copper(II) complexes of beta-substituted hydroxylporphyrins as tumor photosensitizers. Bioorg Med Chem Lett 2006;16:3030–3.
   PubMed Web of Science ®Google Scholar
• Pan D, Zhong XM, Zhao WD, et al. Meso-substituted porphyrin photosensitizers with enhanced near-infrared absorption: synthesis, characterization and biological evaluation for photodynamic therapy. Tetrahedron 2018;74:2677–83.
   Web of Science ®Google Scholar
• Pavani C, Uchoa AF, Oliveira CS, et al. Effect of zinc insertion and hydrophobicity on the membrane interactions and PDT activity of porphyrin photosensitizers. Photochem Photobiol Sci 2009;8:233–40.
   PubMed Web of Science ®Google Scholar
• Zhu SZ, Wu FS, Wang K, et al. Photocytotoxicity, cellular uptake and subcellular localization of amidinophenylporphyrins as potential photodynamic therapeutic agents: an in vitro cell study. Bioorg Med Chem Lett 2015;25:4513–7.
   PubMed Web of Science ®Google Scholar
• Yu Q, Xu WX, Yao YH, et al. Synthesis and photodynamic activities of a new metronidazole-appended porphyrin and its Zn(II) complex. J Porphyrins Phthalocyanines 2015;19:1107–13.
   Web of Science ®Google Scholar
• Brunner H, Schellerer KM, Treittinger B. Synthesis and in vitro testing of hematoporphyrin type ligands in platinum(II) complexes as potent cytostatic and phototoxic antitumor agents. Inorg Chim Acta 1997;264:67–79.
   Web of Science ®Google Scholar
• Lottner C, Bart KC, Bernhardt G, Brunner H. Soluble tetraarylporphyrin-platinum conjugates as cytotoxic and phototoxic antitumor agents. J Med Chem 2002;45:2079–89.
   PubMed Web of Science ®Google Scholar
• Song R, Kim YS, Lee CO, et al. Synthesis and antitumor activity of DNA binding cationic porphyrin–platinum(II) complexes. Tetrahedron Lett 2003;44:1537–40.
   Web of Science ®Google Scholar
• Brunner H, Gruber N. Carboplatin-containing porphyrin–platinum complexes as cytotoxic and phototoxic antitumor agents. Inorg Chim Acta 2004;357:4423–51.
   Web of Science ®Google Scholar
• Naik A, Rubbiani R, Gasser G, Spingler B. Visible-light-induced annihilation of tumor cells with platinum-porphyrin conjugates. Angew Chem 2014;126:7058–61.
   Google Scholar
• Tasso TT, Tsubone TM, Baptista MS, et al. Isomeric effect on the properties of tetraplatinated porphyrins showing optimized phototoxicity for photodynamic therapy. Dalton Trans 2017;46:11037–45.
   PubMed Web of Science ®Google Scholar
• Hu X, Ogawa K, Li S, et al. A platinum functional porphyrin conjugate: an excellent cancer killer for photodynamic therapy. Bull Chem Soc Jpn 2019;92:790–6.
   Web of Science ®Google Scholar
• Yang MQ, Deng JR, Guo D, et al. A folate-conjugated platinum porphyrin complex as a new cancer-targeting photosensitizer for photodynamic therapy. Org Biomol Chem 2019;17:5367–74.
   PubMed Web of Science ®Google Scholar
• Schmitt F, Govindaswamy P, Zava O, et al. Combined arene ruthenium porphyrins as chemotherapeutics and photosensitizers for cancer therapy. J Biol Inorg Chem 2009;14:101–9.
   PubMed Web of Science ®Google Scholar
• Schmitt F, Govindaswamy P, Süss-Fink G, et al. Ruthenium porphyrin compounds for photodynamic therapy of cancer. J Med Chem 2008;51:1811–6.
   PubMed Web of Science ®Google Scholar
• Cunningham M, McCrate A, Nielsen M, Swavey S. Highly efficient visible-light-induced photocleavage of DNA by a ruthenium-substituted fluorinated porphyrin. Eur J Inorg Chem 2009;2009:1521–5.
   Google Scholar
• Schmitt F, Auzias M, Štěpnička P, et al. Sawhorse-type diruthenium tetracarbonyl complexes containing porphyrin-derived ligands as highly selective photosensitizers for female reproductive cancer cells. J Biol Inorg Chem 2009;14:693–701.
   PubMed Web of Science ®Google Scholar
• Zhang JX, Wong KL, Wong WK, et al. Two-photon induced luminescence, singlet oxygen generation, cellular uptake and photocytotoxic properties of amphiphilic Ru(II) polypyridyl-porphyrin conjugates as potential bifunctional photodynamic therapeutic agents. Org Biomol Chem 2011;9:6004–10.
   PubMed Web of Science ®Google Scholar
• Pan J, Jiang L, Chan CF, et al. Excitation energy transfer in ruthenium (II)-porphyrin conjugates led to enhanced emission quantum yield and 1O2 generation. J Lumin 2017;184:89–95.
   Web of Science ®Google Scholar
• Cabrera-González J, Soriano J, Conway-Kenny R, et al. Conway-Kenny R Multinuclear Ru(II) and Ir(III) decorated tetraphenylporphyrins as efficient PDT agents. Biomater Sci 2019;7:3287–96.
   PubMed Web of Science ®Google Scholar
• Barnard PJ, Berners-Price SJ. Targeting the mitochondrial cell death pathway with gold compounds. Coord Chem Rev 2007;251:1889–902.
   Web of Science ®Google Scholar
• Milacic V, Dou QP. The tumor proteasome as a novel target for gold(III) complexes: implications for breast cancer therapy. Coord Chem Rev 2009;253:1649–60.
   PubMed Web of Science ®Google Scholar
• Ott I. On the medicinal chemistry of gold complexes as anticancer drugs. Coord Chem Rev 2009;253:1670–81.
   Web of Science ®Google Scholar
• Che CM, Sun RW, Yu WY, et al. Gold(III) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cells. ChemCommun 2003;21:1718–9.
   Google Scholar
• Wang Y, He QY, Sun RW, et al. Cellular pharmacological properties of gold(III) porphyrin 1a, a potential anticancer drug lead. Eur J Pharmacol 2007;554:113–22.
   PubMed Web of Science ®Google Scholar
• Chen HS, Li J, Shen TT, et al. Gold(III) tetraarylporphyrin phosphonate derivatives as potential anticancer agents. J Chem Res 2012;36:501–5.
   Google Scholar
• Sun L, Chen HS, Zhang ZL, et al. Synthesis and cancer cell cytotoxicity of water-soluble gold(III) substituted tetraarylporphyrin. J Inorg Biochem 2012;108:47–52.
   PubMed Web of Science ®Google Scholar
• Lammer AD, Cook ME, Sessler JL. Synthesis and anti-cancer activities of a water soluble gold(III) porphyrin. J Porphyrins Phthalocyanines 2015;19:398–403.
   PubMed Web of Science ®Google Scholar
• Longevial JF, Cheikh KEI, Aggad D, et al. Porphyrins conjugated with peripheral thiolato gold(I) complexes for enhanced photodynamic therapy. Chem Eur J 2017;23:14017–26.
   PubMed Web of Science ®Google Scholar
• Hu X, Ogawa K, Kiwada T, Odani A. Water-soluble metalloporphyrinates with excellent photo-induced anticancer activity resulting from high tumor accumulation. J Inorg Biochem 2017;170:1–7.
   PubMed Web of Science ®Google Scholar
• Sour A, Jenni S, Orti-Suarez A, et al. Four gadolinium (III) complexes appended to a porphyrin: a water-soluble molecular theranostic agent with remarkable relaxivity suited for MRI tracking of the photosensitizer. Inorg Chem 2016;55:4545–54.
   PubMed Web of Science ®Google Scholar
• Chen YH, Zheng X, Dobhal MP, et al. Methyl pyropheophorbide-a analogues: potential fluorescent probes for the peripheral-type benzodiazepine receptor. Effect of central metal in photosensitizing efficacy. J Med Chem 2005;48:3692–5.
   PubMed Web of Science ®Google Scholar
• da Silva AR, Inada NM, Rettori D, et al. In vitro photodynamic activity of chloro(5,10,15,20-tetraphenylporphyrinato)indium(III) loaded-poly(lactide-co-glycolide) nanoparticles in LNCaP prostate tumour cells. J Photochem Photobiol B 2009;94:101–12.
   PubMed Web of Science ®Google Scholar
• Nakai M, Maeda T, Mashima T, et al. Syntheses and photodynamic properties of glucopyranoside-conjugated indium(III) porphyrins as a bifunctional agent. J Porphyrins Phthalocyanines 2013;17:1173–82.
   Web of Science ®Google Scholar
• Mion G, Gianferrara T, Bergamo A, et al. Phototoxic activity and DNA interactions of water-soluble porphyrins and their rhenium(I) conjugates. ChemMedChem 2015;10:1901–14.
   PubMed Web of Science ®Google Scholar
• Schneider R, Tirand L, Frochot C, et al. Recent improvements in the use of synthetic peptides for a selective photodynamic therapy. Anticancer Agents Med Chem 2006;6:469–88.
   PubMedGoogle Scholar
• Frochot C, Di Stasio B, Vanderesse R, et al. Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity. Bioorg Chem 2007;35:205–20.
   PubMed Web of Science ®Google Scholar
• Srivatsan A, Ethirajan M, Pandey SK, et al. Conjugation of cRGD peptide to chlorophyll a based photosensitizer (HPPH) alters its pharmacokinetics with enhanced tumor-imaging and photosensitizing (PDT) efficacy. Mol Pharmaceutics 2011;8:1186–97.
   PubMed Web of Science ®Google Scholar
• Conway CL, Walker I, Bell A, et al. In vivo and in vitro characterisation of a protoporphyrin IX-cyclic RGD peptide conjugate for use in photodynamic therapy. Photochem Photobiol Sci 2008;7:290–8.
   PubMed Web of Science ®Google Scholar
• Chaleix V, Sol V, Huang YM, et al. RGD-porphyrin conjugates: synthesis and potential application in photodynamic therapy. Eur J Org Chem 2003;2003:1486–93.
   Web of Science ®Google Scholar
• Sibrian-Vazquez M, Jensen TJ, Fronczek FR, et al. Synthesis and characterization of positively charged porphyrin-peptide conjugates. Bioconjugate Chem 2005;16:852–63.
   PubMed Web of Science ®Google Scholar
• Chaloin L, Bigey P, Loup C, et al. Improvement of porphyrin cellular delivery and activity by conjugation to a carrier peptide. Bioconjugate Chem 2001;12:691–700.
   PubMed Web of Science ®Google Scholar
• Vives E. Cellular uptake of the Tat peptide: an endocytosis mechanism following ionic interactions. J Mol Recognit 2003;16:265–71.
   PubMed Web of Science ®Google Scholar
• Sibrian-Vazquez M, Jensen TJ, Hammer RP, et al. Syntheses and cellular studies of water soluble porphyrin-peptide conjugates. Proc Spie 2007;6427:64270A.
   Google Scholar
• Sibrian-Vazquez M, Jensen TJ, Hammer RP, Vicente M. Peptide-mediated cell transport of water soluble porphyrin conjugates. J Med Chem 2006;49:1364–72.
   PubMed Web of Science ®Google Scholar
• Sibrian-Vazquez M, Jensen TJ, Vicente M. Synthesis, characterization, and metabolic stability of porphyrin-peptide conjugates bearing bifunctional signaling sequences. J Med Chem 2008;51:2915–23.
   PubMed Web of Science ®Google Scholar
• Tréhin R, Merkle HP. Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur J Pharm Biopharm 2004;58:209–23.
   PubMed Web of Science ®Google Scholar
• Sehgal I, Sibrian-Vazquez M, Vicente M. Photoinduced cytotoxicity and biodistribution of prostate cancer cell-targeted porphyrins. J Med Chem 2008;51:6014–20.
   PubMed Web of Science ®Google Scholar
• Sibrian-Vazquez M, Jensen TJ, Vicente M. Influence of the number and distribution of NLS peptides on the photosensitizing activity of multimeric porphyrin-NLS. Org Biomol Chem 2010;8:1160–72.
   PubMed Web of Science ®Google Scholar
• Dondi R, Yaghini E, Tewari K, et al. Flexible synthesis of cationic peptide-porphyrin derivatives for light-triggered drug delivery and photodynamic therapy. Org Biomol Chem 2016;14:11488–501.
   PubMedGoogle Scholar
• Abrahamse H, Kruger CA, Kadanyo S, Mishra A. Nanoparticles for advanced photodynamic therapy of cancer. Photomed Laser Surg 2017;35:581–8.
   PubMed Web of Science ®Google Scholar
• Zeng JF, Yang WD, Shi DJ, et al. Porphyrin derivative conjugated with gold nanoparticles for dual-modality photodynamic and photothermal therapies in vitro. ACS Biomater Sci Eng 2018;4:963–72.
   PubMed Web of Science ®Google Scholar
• Xue YD, Tian J, Xu L, et al. Ultrasensitive redox-responsive porphyrin-based polymeric nanoparticles for enhanced photodynamic therapy. Eur Polym J 2019;110:344–54.
   Web of Science ®Google Scholar
• Zhao TT, Wu H, Yao SQ, et al. Nanocomposites containing gold nanorods and porphyrin-doped mesoporous silica with dual capability of two-photon imaging and photosensitization. Langmuir 2010;26:14937–42.
   PubMed Web of Science ®Google Scholar
• Penon O, Marín MJ, Amabilino DB, et al. Iron oxide nanoparticles functionalized with novel hydrophobic and hydrophilic porphyrins as potential agents for photodynamic therapy. J Colloid Interface Sci 2016;462:154–65.
   PubMed Web of Science ®Google Scholar
• Wang D, Niu LJ, Qiao ZY, et al. Synthesis of self-assembled porphyrin nanoparticle photosensitizers. ACS Nano 2018;12:3796–803.
   PubMed Web of Science ®Google Scholar
• Bretin L, Pinon A, Bouramtane S, Ouk C, et al. Photodynamic therapy activity of new porphyrin-xylan-coated silica nanoparticles in human colorectal cancer. Cancers 2019;11:1474.
   Web of Science ®Google Scholar
• Pan D, Liang PP, Zhong XM, et al. Self-assembled porphyrin-based nanoparticles with enhanced near-infrared absorbance for fluorescence imaging and cancer photodynamic therapy. ACS Appl Bio Mater 2019;2:999–1005.
   PubMedGoogle Scholar
• Frimayanti N, Yam ML, Lee HB, et al. Validation of quantitative structure-activity relationship (QSAR) model for photosensitizer activity prediction. Int J Mol Sci 2011;12:8626–44.,
   PubMed Web of Science ®Google Scholar
• Siewert B, Stuppner H. The photoactivity of natural products – An overlooked potential of phytomedicines?. Phytomedicine 2019;60:152985.
   PubMed Web of Science ®Google Scholar